Search

everythinglearnresearchcommunity

for

Search:↓

Early hair loss may predict heart disease.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Testosterone is crucial for development, growth, and various body functions in mammals.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Testosterone's effects on COVID-19 are unclear and need more research.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

Possible link between androgens and COVID-19 severity; more research needed.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Finasteride may cause kidney damage.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.